Health Condition 1: L650- Telogen effluvium
Conditions
Interventions
Intervention1: 1.Moorad ke patte
(Myrtus Communis)
2.Amla(Phylanihus Embelica)
3.Post haleela zard (Terminalia chebula)
4.Post baheda(Terminalia belerica)
5.Pani(Water)
6.Rogahn e gul
: Study subject
Sponsors
National Institute of Unani Medicine Kottigepalya Bangaluru
National Institute of Unani Medicine Bangaluru
Eligibility
Inclusion criteria
Inclusion criteria: Subjects complaining of hair fall and damage. Subjects willing to give a written informed. consent and agree to come for a regular follow up visit. Hair density of >100 and Subjects willing to abide by and comply with the study protocol. Subjects who have not participated in a similar investigation in the past three months. Healthy volunteers with no known allergy as established by medical history. Subjects who do not smoke or drink. Subjects who are not crash dieting. Subjects who agree to refrain from using hair dye/hair colour during the study period. Subjects willing to refrain from any type of hair treatment like perming, straightening etc. during the study duration. Subjects who are willing to refrain from any other oil treatment/hair spa and oral medications for hair growth during the study. Subject having hair length of at least 5 cm.
Exclusion criteria
Exclusion criteria: Subjects who have undergone hair growth treatment within 3 months before screening into the study. Subjects having any active scalp disease such as scalp Psoriasis and tinea capitis which may interfere in the study- dermatologist’s judgement. Subjects who have taken chemotherapy for cancer in the 6 months prior to start of the study or have a plan to do treatments during study. Subjects who have history of alcoholism and/ or psychiatric disorder including trichotillomania. Subjects who have had hair transplant. Subjects who take pharmaceutical product which cause hirsutism (ex. phenytoin) and finasteride for androgenic alopecia. Subjects with a known history or present condition of allergic response/hypersensitivity to any cosmetic ingredients and pharmaceutical products. Subjects consuming alcohol and smoking Subjects on oral medications such as vitamin supplements, including multi-vitamins which will compromise the study. Subjects who are pregnant or lactating or nursing as established with medical history Subjects under medical treatment for hair problems, prescription drugs such as Minoxidil, Finasteride, or any 5 a-reductase inhibitor or light therapy. Subjects undergoing any chemical hair salon treatment-straightening / perming/colour Menopausal female subjects as determined by medical history. Subjects with chronic illness which may influence the cutaneous state. Subjects participating in other similar cosmetic or therapeutic trial within last three months. Subjects with medical history of thyroid disorders. Subjects with any history of underlying uncontrolled medical illness including diabetes mellitus, hypertension, HIV, hepatitis, severe anemia, serious disorder of heart and respiratory apparatus or any other serious medical illness. Subjects who have experienced a known stressful event within the last 6 months such as death in family, miscarriage etc. Inflammatory skin diseases or progressive skin lesion on the scalp (psoriasis, seborrheic dermatitis, sever erythema, sever excoriation, sever sunburn, etc.) Perimenopausal symptoms (irregular menstruations, premenstrual syndrome …) Subject having frizzy hair Subject unable to understand the information given (for linguistic or psychiatric reasons) and to give her consent in writing to participate Subject who has any other hair disorder or hair disease (Ludwig II, III, AA, scarring alopecia …)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decreases in Hairfall in Pull test Wash test Hair density Hair thickness Timepoint: 90days | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Complete blood count, 2.Urine analysis, 3.Serum ferritin and 4.T3, T4, Thyroid stimulating hormone (TSH). Timepoint: 90 Days | — |
Countries
India
Contacts
Public ContactZarnigar
National Institute of Unani Medicine Bangaluru - 560 091
Outcome results
None listed